Haplotype in the IBD5 region is associated with refractory Crohn's disease in Slovenian patients and modulates expression of the SLC22A5 gene

Journal of Gastroenterology

Volumn 46, Issue 9, 2011, Pages 1081-1091

  Repnik, Katja ^a   Potočnik, Uroš ^a  

^a UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Expression quantitative trait locus (eQTL); IBD5; Inflammatory bowel disease

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE;

ADULT; ARTICLE; COLON BIOPSY; COLON FISTULA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SLC22A4 GENE; SLC22A5 GENE; SLOVENIAN; ULCERATIVE COLITIS;

ADULT; AGED; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SLOVENIA;

EID: 80755189894     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0426-6     Document Type: Article

References (44)

1. Weersma RK, van Dullemen HM, Van Der SG, Nolte IM, Kleibeuker JH, Dijkstra G. Review article: inflammatory bowel disease and genetics. Aliment Pharmacol Ther. 2007;26 (Suppl 2):57-65. (Pubitemid 350233321)
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-29. (Pubitemid 34851835)
3. Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet. 2008;9:9-14. (Pubitemid 350277296)
4. Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 2004;5:417-25. (Pubitemid 39139770)
5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411: 599-603. (Pubitemid 32531408)
6. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-6. (Pubitemid 32531409)
7. Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet. 2003;11: 237-44. (Pubitemid 36511862)
8. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004;99:2393-404. (Pubitemid 40039371)
9. Zhang H, Massey D, Tremelling M, Parkes M. Genetics of inflammatory bowel disease: clues to pathogenesis. Br Med Bull. 2008;87:17-30.
10. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 2001;29:223-8. (Pubitemid 32952663)
11. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 2000;66:1863-70. (Pubitemid 30480093)
12. Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr. 1998;18:39-61. (Pubitemid 28366860)
13. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther. 1999;290:1482-92. (Pubitemid 29400294)
14. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004;36:471-5. (Pubitemid 38620030)
15. Noble CL, Nimmo ER, Drummond H, Ho GT, Tenesa A, Smith L, et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology. 2005;129:1854-64. (Pubitemid 41772964)
16. Torok HP, Glas J, Tonenchi L, Lohse P, Muller-Myhsok B, Limbersky O, et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut. 2005;54: 1421-7. (Pubitemid 41375199)
17. Palmieri O, Latiano A, Valvano R, D'Inca R, Vecchi M, Sturniolo GC, et al. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2006;23:497-506. (Pubitemid 43382004)
18. Tosa M, Negoro K, Kinouchi Y, Abe H, Nomura E, Takagi S, et al. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease. Scand J Gastroenterol. 2006; 41:48-53. (Pubitemid 43030891)
19. Bene J, Magyari L, Talian G, Komlosi K, Gasztonyi B, Tari B, et al. Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World J Gastroenterol. 2006;12:5550-3. (Pubitemid 44501819)
20. Giallourakis C, Stoll M, Miller K, Hampe J, Lander ES, Daly MJ, et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet. 2003;73:205-11. (Pubitemid 36793792)
21. Noble CL, Abbas AR, Cornelius J, Lees CW, Ho GT, Toy K, et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut. 2008;57:1398-405.
22. Reinhard C, Rioux JD. Role of the IBD5 susceptibility locus in the inflammatory bowel diseases. Inflamm Bowel Dis. 2006;12:227-38.
23. Weersma RK, Zhou L, Nolte IM, Van Der Steege G, van Dullemen HM, Oosterom E, et al. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm Bowel Dis. 2008;14:1615-22.
24. Huang Y, Zheng J, Przytycka TM. Discovery of regulatory mechanisms from gene expression variation by eQTL analysis. In: Chen JY, Lonardi S, editors. Biological data mining. Boco Raton: Chapman & Hall/CRC; 2009. p. 205-28.
25. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40:955-62.
26. Potocnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun. 2004;5:530-9. (Pubitemid 39529969)
27. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus and implications. Gut. 2006;55:749-53. (Pubitemid 43764536)
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-8. (Pubitemid 34164012)
29. Gazouli M, Mantzaris G, Archimandritis AJ, Nasioulas G, Anagnou NP. Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J Gastroenterol. 2005;11:7525-30. (Pubitemid 43126038)
30. Lakner L, Csongei V, Sarlos P, Jaromi L, Safrany E, Varga M, et al. IGR2096a-1 T and IGR2198a-1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients. Int J Colorectal Dis. 2009;24:503-7.
31. Magyari L, Melegh B. Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients. Orv Hetil. 2009;150:81-8.
32. Li M, Gao X, Guo CC, Wu KC, Zhang X, Hu PJ. OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J Gastroenterol. 2008;14:4923-7.
33. Nakahara S, Arimura Y, Saito K, Goto A, Motoya S, Shinomura Y, et al. Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory bowel disease in Japan. Dis Colon Rectum. 2008;51:598-603.
34. Franke A, Hampe J, Rosenstiel P, Becker C, Wagner F, Hasler R, et al. Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS One. 2007;2:e691.
35. Armuzzi A, Ahmad T, Ling KL, de Silva A, Cullen S, van Heel D, et al. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut. 2003;52: 1133-9. (Pubitemid 36877425)
36. Urcelay E, Mendoza JL, Martinez A, Fernandez L, Taxonera C, az-Rubio M, et al. IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab. World J Gastroenterol. 2005;11:1187-92. (Pubitemid 40353007)
37. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
38. Gilad Y, Rifkin SA, Pritchard JK. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet. 2008;24:408-15.
39. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, et al. A genome-wide association study of global gene expression 3. Nat Genet. 2007;39:1202-7. (Pubitemid 47482680)
40. Heap GA, Trynka G, Jansen RC, Bruinenberg M, Swertz MA, Dinesen LC, et al. Complex nature of SNP genotype effects on gene expression in primary human leucocytes. BMC Med Genomics. 2009;2:1.
41. Palacios R, Comas D, Elorza J, Villoslada P. Genomic regulation of CTLA4 and multiple sclerosis. J Neuroimmunol. 2008;203: 108-15.
42. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, et al.Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008;40:395-402. (Pubitemid 351450876)
43. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448:470-3. (Pubitemid 47123521)
44. Rebouche CJ. Carnitine function and requirements during the life cycle. FASEB J. 1992;6:3379-86. (Pubitemid 23007103)